Robert Doebele - Feb 15, 2023 Form 4 Insider Report for Rain Oncology Inc. (RAIN)

Role
President, Chief Scientific Officer
Signature
/s/ Nelson Cabatuan, Attorney-in-fact for Robert Doebele
Stock symbol
RAIN
Transactions as of
Feb 15, 2023
Transactions value $
$0
Form type
4
Date filed
2/17/2023, 05:18 PM
Previous filing
Jul 7, 2022
Next filing
Aug 11, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAIN Stock Option (Right to Buy) Award $0 +123K $0.00 123K Feb 15, 2023 Common Stock 123K $9.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 123,325 shares of the Issuer's common stock, one quarter of which will vest on February 15, 2024, with the remaining three quarters vesting in equal monthly installments through February 15, 2027, subject to the Reporting Person's continued service to the Issuer.

Remarks:

President, Chief Scientific Officer